Skip to content

Motivational Interviewing for HCV Elimination

Assessing a Model for Hepatitis C Elimination: Measuring Patient and Health System Outcomes After Motivational Interviewing Interventions to Increase Treatment Engagement

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03804814
Enrollment
2
Registered
2019-01-15
Start date
2019-05-21
Completion date
2021-10-04
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Keywords

Motivational Interviewing, Healthcare delivery

Brief summary

This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called Motivational Interviewing (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.

Interventions

Motivational Interviewing is a directive, client-centered counselling style intended to elicit behavior change by helping patients reach health goals through their own desires and actions. A certified and experienced Motivational Interviewing trainer will develop and deliver the curriculum to healthcare providers.

Sponsors

Nova Scotia Health Authority
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Patient Inclusion Criteria: * Willingness to participate and provide informed consent * Positive HCV RNA Result * ≥18 years of age Patient

Exclusion criteria

* Unwilling or unable to provide consent Health Care Provider Inclusion Criteria: * Willingness to participate and provide informed consent * Has a hepatitis C care experience Health Care Provider

Design outcomes

Primary

MeasureTime frameDescription
HCV Treatment CompletionThrough study completion, an average of 2 yearsTo measure the number of patients who complete HCV therapy

Secondary

MeasureTime frame
Number of unique Hepatitis C related and unrelated health system visitsThrough study completion, an average of 2 years
Number of scheduled and attended medical care appointmentsThrough study completion, an average of 2 years
Self-reported intent to initiate and maintain HCV treatment assessed by questionnaireThrough study completion, an average of 2 years
Time from care engagement to treatment initiationThrough study completion, an average of 2 years
Time to complete prescribed HCV treatment courseThrough study completion, an average of 2 years
Percentage of eligible individuals that initiate HCV therapyThrough study completion, an average of 2 years
Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaireThrough study completion, an average of 2 years

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026